e-drug
[Top] [All Lists]

[e-drug] Buffer Stock for emergency supply of key HIV & AIDS Products

E-DRUG: Buffer Stock for emergency supply of key HIV & AIDS Products
--------------------------------------------------------------------

dear E-druggers,

Emergency Buffer Stock Supply for the Supply of key HIV & AIDS Products

The emergency buffer stock for the supply of key HIV & AIDS products for
treatment programmes in mainly Sub Sahara Africa is now fully
operational. 

Funded by the Dutch Ministry of Foreign Affairs and Development
Cooperation, this buffer stock is offering a fall-back supply service to
HIV & AIDS treatment programmes in Africa that may run out of supplies
for one reason or other. The Ministry has contracted IDA Solutions and
its South African affiliate ARV Access for Africa (AA4A) to implement
this service. The service is able to mobilize stock within 24 hours and
reach 80% of Sub Sahara Africa destinations within one week. AA4A are
collaborating with Pharmaceutical Health Distributors (PHD) based in
Pretoria, for the handling of the logistical operations. 

All the products available from the emergency buffer stock comply with
either WHO or FDA quality standards with most of them included in the
Standard Treatment Guidelines of most of the receiving countries. The
basic list of products currently available now for supply from the
project is composed of:

*        Lamivudine/Stavudine/Nevirapine 150mg/40mg/200mg  60 tablets
*        Lamivudine/Stavudine/Nevirapine 150mg/30mg/200mg   60 tablets
*        Lamivudine/Zidovudine/Nevirapine 150mg/300mg/200mg 60 tablets
*        Lamivudine/Zidovudine 150mg/300mg 60 tablets
*        Efavirenz 600mg 30 tablets
*        Lamivudine/Stavudine 150mg/40mg  60 tablets
*        Lamivudine/Stavudine 150mg/30mg  60 tablets
*        Nelfinavir (as mesilate) 250mg  270 tablets
*        Abacavir (as sulphate) 300mg blister (6x10) tablets
*        Tenofovir disoproxil fumarate 300mg [Viread] 30 tablets
 
In addition to the above list of products, the project is able to source
and supply at short notice other related products that may be required
by HIV & AIDS treatment programmes in Sub Sahara Africa and beyond.

The project is pleased to advise that the first delivery of ARVs was
made to Togo during mid July 2007. The project is currently responding
to enquiries being received from various countries for the supply of
emergency ARV requirements.

In order to ensure the provision of the required service to HIV & AIDS
treatment programmes, we would like to elicit your ideas on expanding
the product list, presentations and possible adaptations of the 1st line
treatment regime based on your practical experience.

We would also like to hear from you what test kits and reagents need to
be included in the product list on offer.

For more information contact:

Melinda Wannenburg
ARV Access for Africa- 
78 Hazelwood Street
Menlo Park 0081
Pretoria
South Africa
Tel +27 12 460 0914
Fax +27 12 346 1196
mailto: info@aa4a.co.za
http://www.aa4a.co.za

<Prev in Thread] Current Thread [Next in Thread>
  • [e-drug] Buffer Stock for emergency supply of key HIV & AIDS Products, Melinda Wannenburg <=